General Information
Version
5.01
Revision date
2025-12-20
Product name
TEHOMET CARAMEL NO FLOW BASE
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
54.8% (oral), 62% (dermal), 89.1% (inhalation)
Signal word
Warning
Hazard statements
May form combustible dust concentrations in air.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
Moisture-sensitive material. Keep container tightly closed. Keep away from heat, sparks, open flames and hot surfaces. - No smoking. Sanding and grinding dusts may be harmful if inhaled. Prevent dust accumulation. Skin contact to isocyanate monomer may lead to allergic lung reaction. Based on the properties of the isocyanate components and considering toxicological data on similar mixtures, this mixture may cause acute irritation and/or sensitization of the respiratory system, leading to an asthmatic condition, wheezing and tightness of the chest. Sensitized persons may subsequently show asthmatic symptoms when exposed to atmospheric concentrations well below the OEL. Repeated exposure may lead to permanent respiratory disability. Persons with a history of skin sensitization problems or asthma, allergies or chronic or recurrent respiratory disease should not be employed in any process in which this product is used. Emits toxic fumes when heated. Hazards identified when used : Apply generous quantities of fresh calcium gluconate gel to all areas. Get immediate medical attention.
2.3 Other hazards
Fine dust clouds may form explosive mixtures with air. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat.
2.1 Classification of the substance or mixture
Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 54.8% (oral), 62% (dermal), 89.1% (inhalation)